机构:[1]Renal Division and Institute of Nephrology, Sichuan Academy of Medical Science & Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, Sichuan, China.四川省人民医院[2]Renal and Metabolic Division, The George Institute for Global Health, University of New South Wales Australia, Newtown, NSW, Australia.[3]Department of Renal Medicine, Concord Repatriation General Hospital, Concord Clinical School, University of Sydney, Camperdown, NSW, Australia.[4]Faculty of Medicine, Health and Human Sciences, Macquarie University, Sydney, NSW, Australia.[5]Internal Medicine, Louisiana State University Health Science at Shreveport, Shreveport, LA, United States.[6]The Faculty of Health Sciences and Medicine, Bond University, Gold Coast, QLD, Australia.
General Program of
National Natural Science Foundation of China (81170680), the
Basic Applied Projects of Science and Technology Department
of Sichuan Province (2018JY0332), the Youth Foundation of
Sichuan Academy of Medical Sciences, and Sichuan Provincial
People’s Hospital (3030503851). AW was supported by the
NationalHeart Foundation Vanguard Grant, Australia (106075).
第一作者机构:[1]Renal Division and Institute of Nephrology, Sichuan Academy of Medical Science & Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, Sichuan, China.
共同第一作者:
通讯作者:
通讯机构:[2]Renal and Metabolic Division, The George Institute for Global Health, University of New South Wales Australia, Newtown, NSW, Australia.[3]Department of Renal Medicine, Concord Repatriation General Hospital, Concord Clinical School, University of Sydney, Camperdown, NSW, Australia.[4]Faculty of Medicine, Health and Human Sciences, Macquarie University, Sydney, NSW, Australia.
推荐引用方式(GB/T 7714):
Wang Wei,Wu Song,Wang Amanda Y,et al.Thrombomodulin activation driven by LXR agonist attenuates renal injury in diabetic nephropathy[J].FRONTIERS IN MEDICINE.2023,9:doi:10.3389/fmed.2022.916620.
APA:
Wang Wei,Wu Song,Wang Amanda Y,Wu Tao,Luo Haojun...&Ding Hanlu.(2023).Thrombomodulin activation driven by LXR agonist attenuates renal injury in diabetic nephropathy.FRONTIERS IN MEDICINE,9,
MLA:
Wang Wei,et al."Thrombomodulin activation driven by LXR agonist attenuates renal injury in diabetic nephropathy".FRONTIERS IN MEDICINE 9.(2023)